Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of nicotinic acetylcholine receptor (nAChR) modulators. It plays a role in creating compounds aimed at treating neurological disorders such as Alzheimer's disease, schizophrenia, and depression. Its structure supports binding selectivity to specific receptor subtypes, enhancing drug efficacy and reducing side effects. Also utilized in research settings to explore new pathways in neuropharmacology and cognitive function enhancement.